Nevro Corp. (NVRO)
NYSE: NVRO · IEX Real-Time Price · USD
9.10
-0.37 (-3.91%)
At close: Jul 19, 2024, 4:00 PM
50.00
+40.90 (449.45%)
After-hours: Jul 20, 2024, 1:30 PM EDT
Nevro Market Cap
Nevro has a market cap or net worth of $334.23 million as of July 22, 2024. Its market cap has decreased by -61.36% in one year.
Market Cap
334.23M
Enterprise Value
270.04M
1-Year Change
-61.36%
Ranking
Category
Stock Price
$9.10
Market Cap Chart
Since November 6, 2014, Nevro's market cap has decreased from $574.20M to $334.23M, a decrease of -41.79%. That is a compound annual growth rate of -5.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 334.20M | -57.10% |
| Dec 29, 2023 | 779.10M | -44.47% |
| Dec 30, 2022 | 1.40B | -50.42% |
| Dec 31, 2021 | 2.83B | -52.52% |
| Dec 31, 2020 | 5.96B | 63.52% |
| Dec 31, 2019 | 3.64B | 210.75% |
| Dec 31, 2018 | 1.17B | -42.66% |
| Dec 29, 2017 | 2.05B | -2.13% |
| Dec 30, 2016 | 2.09B | 10.82% |
| Dec 31, 2015 | 1.89B | 96.32% |
| Dec 31, 2014 | 960.70M | 67.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Q32 Bio | 351.81M |
| Xeris Biopharma Holdings | 350.63M |
| AC Immune | 345.21M |
| Cabaletta Bio | 342.28M |
| ModivCare | 335.24M |
| Kamada | 332.20M |
| ADC Therapeutics | 331.02M |
| Inozyme Pharma | 329.69M |